| The opioid receptor system is characterized by at least three types of receptors (μ, δ, κ) and several receptor subtypes have been postulated. Receptor-specific agonists may provide analgesia without the deleterious side effects of the commonly administered μ-receptor agonists. In our laboratories, there is an ongoing effort to synthesize potent and δ-receptor selective peptide opioids. Peptidomimetics are designed, synthesized and incorporated into enkephalin analogs, and the resulting target compounds are subjected to biological and conformational analyses.; A new asymmetric synthesis of α-methyl-D-cysteine was accomplished. The incorporation of αMe-D-Cys into [αMe-D-Cys2, Cys5] enkephalin resulted in an active, but non-selective δ-receptor analog. The incorporation of αMe-D-Cys into [D-Cys2, αMe-D-Cys 5] resulted in a highly potent and δ-selective ligand.; Several β,β-dimethylated amino acids were synthesized using an asymmetric Strecker reaction. A new methodology to prepare α,α-dialkylated-β-lactams via Mannich-type reactions was successfully achieved. Different conditions were investigated to transform these β-lactams into the corresponding β,β-dialkylated aspartic acids and β,β-dialkylated diaminobutyric acids.; On the basis of results obtained for previously synthesized bridged-enkephalins, we undertook the parallel synthesis of novel diacyl-bridged enkephalin analogs (DABE). From the series of compounds synthesized, diacyl maloyl DABE exhibits the best δ-receptor selectivity. |